Cephalon


Also found in: Wikipedia.
Translations
céphalon
Mentioned in ?
References in periodicals archive ?
Kevin Buchi, former chief executive officer of Cephalon, Inc., and TetraLogic Pharmaceuticals Corp., and Cynthia Smith, former chief commercial officer of ZS Pharma, Inc., to its board of directors, the company said.
The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust rules.
TRISENOX was reportedly acquired from CTI BioPharma by Cephalon Inc, which was subsequently acquired by Teva.
PITTSBURGH -- Mylan NV has agreed to pay $96.5 million to settle a class-action suit claiming that it conspired with Cephalon Inc.
According to the Federal Trade Commission, the pharmaceutical company Cephalon, which makes Provigil, a drug used to treat sleep disorders, sued four generic drugmakers in 2005-06 for patent infringement and later paid them more than $300 million collectively to drop their challenges to Provigil's patents and to stop selling their generics for six years, until April 2012.
Teva Pharmaceutical Industries, the parent company of Cephalon, is now experiencing the downside of that risk.
It had already examined this over-the-counter activity when Teva took it over from another generic pharmaceutical firm, Cephalon of the United States, for 4.5 billion (see Europolitics 4286).
Melbourne, Australia, Oct 20, 2011 - (ABN Newswire) - Mesoblast Limited (ASX:MSB) and its strategic alliance partner Cephalon Inc.
14 October 2011 - The European Commission (EC) has conditionally cleared Israeli drugmaker Teva Pharmaceuticala[euro](tm)s (TLV:TEVA, NASDAQ:TEVA) nearly USD7bn (EUR5.1bn) deal to buy US biopharmaceutical firm Cephalon (NASDAQ:CEPH), the two companies said in a joint press release.
Cephalon by the generic pharmaceutical company Teva of Israel.
last year, and will fork over another $6.8 billion to pick up Cephalon,
Cephalon and Mesoblast have entered into a strategic alliance to develop and commercialize Mesoblast's Mesenchymal Precursor Cell (MPC) therapeutics for hematopoietic stem cell transplantation in cancer patients, as well as degenerative conditions of the central nervous and cardiovascular systems, including congestive heart failure.